2018
DOI: 10.1089/ped.2018.0880
|View full text |Cite
|
Sign up to set email alerts
|

Bethanechol in Tracheomalacia: Two Case Series and a Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
2

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 6 publications
0
7
0
1
Order By: Relevance
“…Stimulation of the muscarinic receptors in the airways should normally produce bronchospasm, but it seems to actually "open" an airway that is floppy due to malacia by increasing the trachealis muscle tone. There are no RCTs on its use but in a small series it appeared to be safe 144 .…”
Section: Recommendations On Therapeutic Interventions VII Management Of Tracheobronchomalaciamentioning
confidence: 96%
“…Stimulation of the muscarinic receptors in the airways should normally produce bronchospasm, but it seems to actually "open" an airway that is floppy due to malacia by increasing the trachealis muscle tone. There are no RCTs on its use but in a small series it appeared to be safe 144 .…”
Section: Recommendations On Therapeutic Interventions VII Management Of Tracheobronchomalaciamentioning
confidence: 96%
“…Although a similar approach can be provided with pressure‐targeted modes of ventilation, a volume‐targeted mode of synchronized ventilation facilitates continued delivery of the larger rated breaths even when airway resistance is altered by secretions or other changes in lung mechanics. Finally, in treating severe airways malacia, some centers have reported successful treatment using cholinergic stimulation with pharmacologic agents (such as enteral bethanechol) to increase airway smooth muscle tone and prevent collapse 31,32 …”
Section: Acute Versus Chronic Strategies For Ventilation In Sbpdmentioning
confidence: 99%
“…En el contexto de episodios obstructivos bronquiales recidivantes (SBOR), que se imbrican con las TM, ya que comparten el mismo grupo etario de mayor prevalencia (menores de 3 años), se debe evitar los broncodilatadores β2 adrenérgicos, ya que pueden empeorar la obstrucción de la vía aérea al disminuir el tono de la musculatura lisa traqueobronquial (2), en cambio sí se ha documentado un efecto favorable del antimuscarínico bromuro de ipratropio (26), lo que puede deberse a su acción en las secreciones o en el tono de las vías aéreas. El uso de un agonista muscarínico inhalado (bethanechol) ha mostrado mejor calidad de vida en un par de series de pacientes (27) pero no se usa rutinariamente (3). También en el contexto de SBOR hay un excesivo uso de corticoides inhalados en TM-TBM y en la medida que se diagnostique precozmente la malacia de la vía aérea habrá un menor uso erróneo de TM= traqueomalacia, IRA = infección respiratoria aguda, PEP = presión positiva espiratoria, SBO = sindrome bronquial obstructivo, ERGE = enfermedad por reflujo gastroesofágico, CPAP = presión positiva contínua en vía aérea, BiPAP = presión positiva en vía aérea de dos niveles, CNAF = cánula nasal de alto flujo tratamientos antiasmáticos.…”
Section: Tratamientounclassified